eMedicine Specialties > Urology > Infections and Related Inflammatory Conditions

Trigonitis: Differential Diagnoses & Workup

Author: Scott Rutchik, MD, Assistant Professor, Department of Surgery, Division of Urology, University of Connecticut School of Medicine
Contributor Information and Disclosures

Updated: May 13, 2009

Differential Diagnoses

Urinary Tract Infection, Females

Other Problems to Be Considered

Malakoplakia of the bladder
Squamous cell carcinoma of the bladder
Leukoplakia of the bladder3

Workup

Laboratory Studies

  • If the patient has irritative voiding symptomatology, urinalysis with cultures and sensitivities (in select cases) may be conducted to exclude infection.

Imaging Studies

  • Imaging studies are not normally useful in diagnosing so-called trigonitis. However, Sugaya et al reported that ultrasonographic examination of the bladder in patients with trigonitis may reveal a thickening of the bladder-neck mucosa.4

Procedures

  • Cystoscopy with bladder biopsy is rarely warranted in young females but should be performed in males with this lesion or in females with hematuria.

Histologic Findings

Squamous metaplasia of the trigone is composed of stratified squamous epithelium that often contains abundant glycogen. If the lesion is benign, there is usually little atypia. The basal cell layer has prominent nuclei with condensed chromatin and nucleoli. The surface cells are linked by desmosomes and are longitudinally oriented. Jost et al demonstrated a mitotic index of these lesions of 0.17%, larger than the expected value of 0%.

Keratinization is a somewhat more ominous sign because these lesions are more commonly associated with frank carcinoma. Such lesions usually are referred to as leukoplakia. Benson et al determined that 21% of patients with urothelial leukoplakia progressed to malignancy.

More on Trigonitis

Overview: Trigonitis
Differential Diagnoses & Workup: Trigonitis
Treatment & Medication: Trigonitis
Follow-up: Trigonitis
Multimedia: Trigonitis
References
Further Reading
[ CLOSE WINDOW ]

References

  1. Heymann A. Die cystitis trigoni der frau. Zentralbl Kr Harn Sex. 1905;16:422-33.

  2. Cifuentes L. Epithelium of vaginal type in the female trigone: the clinical problem of trigonitis. J Urol. 1947;57:1028-37.

  3. Neimark AI, Vasil'chenko SI, Il'inskaia EV, Taranina TS, Lebedeva RN, Isachenko SI, et al. [Special features of chronic cystitis with leukoplasional changes of a mucous environment women's urinary bladder]. Voen Med Zh. Jun 2007;328(6):58-61. [Medline].

  4. Sugaya K, Nishijima S, Oda M, et al. Transabdominal vesical sonography of urethral syndrome and stress incontinence. Int J Urol. Jan 2003;10(1):36-42. [Medline].

  5. Benson RC Jr, Swanson SK, Farrow GM. Relationship of leukoplakia to urothelial malignancy. J Urol. Mar 1984;131(3):507-11. [Medline].

  6. Henry L, Fox M. Histological findings in pseudomembranous trigonitis. J Clin Pathol. Oct 1971;24(7):605-8. [Medline].

  7. Jost SP, Gosling JA, Dixon JS. The fine structure of human pseudomembranous trigonitis. Br J Urol. Nov 1989;64(5):472-7. [Medline].

  8. Locke JR, Hill DE, Walzer Y. Incidence of squamous cell carcinoma in patients with long-term catheter drainage. J Urol. Jun 1985;133(6):1034-5. [Medline].

  9. Long ED, Shepherd RT. The incidence and significance of vaginal metaplasia of the bladder trigone in adult women. Br J Urol. Apr 1983;55(2):189-94. [Medline].

  10. Mueller SC, Thueroff JW, Rumpelt HJ. Urothelial leukoplakia: new aspects of etiology and therapy. J Urol. May 1987;137(5):979-83. [Medline].

  11. Murphy WM. Diseases of the urinary bladder, urethra, ureters, and renal pelves: squamous metaplasia. Urological Pathology. 1997;60-2.

  12. Tyler DE. Stratified squamous epithelium in the vesicle trigone and urethra: findings correlated with menstrual cycle and age. Am J Anat. 1962;111:319-25.

[ CLOSE WINDOW ]

Further Reading

Clinical guidelines

ACR Appropriateness Criteria® recurrent lower urinary tract infections in women.
American College of Radiology - Medical Specialty Society. 1995 (revised 2005). 6 pages. [NGC Update Pending] NGC:004608

Referral guidelines for suspected cancer in adults and children.
National Collaborating Centre for Primary Care - National Government Agency [Non-U.S.]. 2005 Jun. 791 pages. NGC:004465

Clinical trials

Evaluation of Non-Invasive Assay(s) for the Detection of Bladder Cancer

Quantitative and Qualitative Changes in Neural Efferent Receptors

Quality of Life and Symptom Management in Patients With Bladder Cancer

Related eMedicine topics

Urinary Tract Infection, Females

Urethral Syndrome

[ CLOSE WINDOW ]

Keywords

trigonal squamous metaplasia, pseudomembranous trigonitis, bladder leukoplakia, bladder cancer, cystitis trigoni, true trigonal membrane, trigonal nonkeratinizing squamous metaplasia, trigone leukoplakia, trigonal leukoplakia, squamous trigonal metaplasia, bladder disorder, trigone disorder

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Scott Rutchik, MD, Assistant Professor, Department of Surgery, Division of Urology, University of Connecticut School of Medicine
Scott Rutchik, MD is a member of the following medical societies: American Urological Association
Disclosure: Nothing to disclose.

Medical Editor

Leonard Gabriel Gomella, MD, FACS, The Bernard W Godwin Professor of Prostate Cancer Chairman, Department of Urology, Associate Director of Clinical Affairs, Kimmel Cancer Center, Thomas Jefferson University
Leonard Gabriel Gomella, MD, FACS is a member of the following medical societies: American Association for Cancer Research, American College of Surgeons, American Medical Association, American Society for Laser Medicine and Surgery, American Urological Association, Sigma Xi, Society for Basic Urologic Research, Society of University Urologists, and Society of Urologic Oncology
Disclosure: GSK Consulting fee Consulting; Astra Zeneca Honoraria Speaking and teaching; Watson Pharmaceuticals Consulting fee Consulting

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

CME Editor

J Stuart Wolf Jr, MD, FACS, David A Bloom Professor of Urology, Director of Division of Minimally Invasive Urology, Department of Urology, University of Michigan
J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology
Disclosure: Terumo Corporation Consulting fee Consulting; Omeros Corporation Consulting fee Consulting

Chief Editor

Edward David Kim, MD, FACS, Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center
Edward David Kim, MD, FACS is a member of the following medical societies: American College of Surgeons, American Society for Reproductive Medicine, American Society of Andrology, American Urological Association, and Tennessee Medical Association
Disclosure: Lilly Consulting fee Consulting; Astellas Consulting fee Speaking and teaching; Indevus Consulting fee Speaking and teaching

RELATED MEDSCAPE ARTICLES
Articles
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.